Lu Chen
Florence Nightingale Foundation
ORCID: 0000-0003-2906-2507Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 9 papers. Top paper: “Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)”.
Dandan Guo, Zhongliang Jiang, Rongsheng Tong, Peidu Jiang, Lan Bai +6 more
Xuan Lu, Jingyi Huang, Hongchao He, Li Chen, Yihan Liu +8 more
Lu Chen, Lichun Wang, Jiangying Li
Zhenghui Xu, Yu Fu, Lu Chen, Junli Zhang
Zhao-Feng Bi, Kai Chu, Li Zhang, Lu Chen, Kong-Xin Zhu +19 more
Yongxin Wei, Shuang Liu, Lu Chen, Xuhui Wang, Zihao Liu +8 more
Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli +36 more
John K. Simmons, Sayeh Gorjifard, Aleksandra M. Michalowski, Kelli M. Wilson, Xiaohu Zhang +10 more
Waiping Shan, Shiyan Yu, Shunli Rui, Chenzhen Du, Zhiqiang Huo +9 more